Payer & Market Access Expert — Gross-to-Net & Formulary Strategy
Remote — US-based or deep US-market experience · Part-time · Posted Aug 5, 2026 · Still listed Nov 3, 2026 · $175-200/hr
Is Mercor legit? Read our evidence-based Mercor review.
Many AI evaluation platforms screen applicants with a qualification test or interview. Module 1 of our AI Evaluator Certification is a free introduction to the judgment those screens look for.
Start the free modulePosted by Mercor. Annotation Academy is not the employer; apply on Mercor's site.
Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a payer / market access expert for a paid pilot, with the potential to continue as the work scales.
Responsibilities
Create and critique rubrics that analyze commercial drugs and drug-development programs
Set and pressure-test gross-to-net and formulary-tier assumptions by drug class
Judge whether coverage, rebating, and tiering assumptions reflect how payers actually behave
Apply this across the pilot's set of drugs and drug classes
Requirements
US-based payer / market access professional
Familiarity with biotech/pharma development programs
Hands-on with gross-to-net, rebates, and formulary tiering by drug class
5+ years in market access, pricing & reimbursement, or managed markets
Engagement Details
Duration: Approximately 10–20 hours over a 1–2 week pilot
Remote — US-based
Why Participate
Help improve expert AI evaluation of drugs and drug-development programs
Recurring engagement for strong contributors
Listing sourced from Mercor. Annotation Academy is independent of these platforms and does not guarantee work or pay. See our disclosures.